Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases.

Dae Yul Yang Won-Woo Seo Rae Woong Park Sang Youl Rhee Jae Myung Cha Yoon Soo Hah Chang Won Jeong Kyung-Jin Kim Hyeon Jong Yang Do Kyung Kim Ji Yong Ha

Published in: The world journal of men's health (2024)

Using real-world databases, the present study demonstrated that dutasteride was not associated with a lower risk of prostate cancer than finasteride in patients with BPH.

Keyphrases

benign prostatic hyperplasia
prostate cancer
lower urinary tract symptoms
radical prostatectomy
big data
randomized controlled trial
clinical trial
machine learning
artificial intelligence
study protocol